Key facts
- This page summarizes Thomas Englese's Form 4 filing for AZIYO BIOLOGICS, INC. (ELUT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Mar 2023, 20:18.
Thomas Englese - 08 Mar 2023 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)
- Reporting relationship
- CHIEF COMMERCIAL OFFICER
- Issuer ticker
- ELUT
- Reported as of
- 08 Mar 2023
- Net transaction value
- -$1,243
- SEC form
- 4
- Accepted by SEC
- 09 Mar 2023, 20:18:07 UTC
- Prior SEC filing
- 12 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeffrey Hamet, Attorney-in-Fact for Thomas Englese
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Thomas Englese filed Form 4 for AZIYO BIOLOGICS, INC. (ELUT) on 09 Mar 2023.
Change
- Previous filing in this sequence was filed on 12 Sep 2022.
- Current net transaction value: -$1,243.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AZYO
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +937
- Change %
- +5.4%
- Price
- $0.000000
- Shares after
- 18,206
- Date
- 08 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
AZYO
transaction
Class A Common Stock
Sale
- Transaction value
- $1,243
- Shares
- -289
- Change %
- -1.6%
- Price
- $4.30
- Shares after
- 17,917
- Date
- 09 Mar 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AZYO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -937
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 1,875
- Date
- 08 Mar 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 937
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs").
Footnote F2
Represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
Footnote F3
On March 8, 2021, the Reporting Person was granted 3,750 RSUs, vesting in four substantially equal annual installments beginning on March 8, 2022.